Richard Trohman
Concepts (261)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pacemaker, Artificial | 16 | 2021 | 32 | 5.290 |
Why?
| Atrial Fibrillation | 21 | 2022 | 197 | 5.120 |
Why?
| Catheter Ablation | 16 | 2022 | 76 | 5.100 |
Why?
| Cardiac Pacing, Artificial | 17 | 2022 | 63 | 4.260 |
Why?
| Defibrillators, Implantable | 9 | 2019 | 31 | 3.890 |
Why?
| Pulmonary Veins | 5 | 2020 | 20 | 3.400 |
Why?
| Arrhythmias, Cardiac | 15 | 2022 | 158 | 3.240 |
Why?
| Cardiac Resynchronization Therapy | 8 | 2021 | 23 | 2.960 |
Why?
| Electrocardiography | 18 | 2022 | 209 | 2.960 |
Why?
| Heart Failure | 9 | 2020 | 232 | 2.860 |
Why?
| Bundle of His | 10 | 2022 | 29 | 2.570 |
Why?
| Anti-Arrhythmia Agents | 7 | 2021 | 101 | 2.240 |
Why?
| Tachycardia, Ventricular | 7 | 2022 | 35 | 1.980 |
Why?
| Cryosurgery | 3 | 2020 | 30 | 1.830 |
Why?
| Heart Rate | 8 | 2020 | 161 | 1.520 |
Why?
| Body Surface Potential Mapping | 2 | 2019 | 7 | 1.500 |
Why?
| Humans | 76 | 2022 | 31481 | 1.500 |
Why?
| Amiodarone | 4 | 2018 | 28 | 1.370 |
Why?
| Cardiac Resynchronization Therapy Devices | 4 | 2020 | 10 | 1.320 |
Why?
| Electrodes, Implanted | 5 | 2015 | 44 | 1.220 |
Why?
| Action Potentials | 5 | 2020 | 143 | 1.200 |
Why?
| Anticoagulants | 8 | 2021 | 151 | 1.090 |
Why?
| Device Removal | 2 | 2015 | 101 | 1.060 |
Why?
| Vena Cava, Superior | 2 | 2015 | 6 | 1.050 |
Why?
| Radiography, Interventional | 2 | 2020 | 29 | 0.990 |
Why?
| Bundle-Branch Block | 3 | 2017 | 12 | 0.970 |
Why?
| Heart Ventricles | 7 | 2022 | 218 | 0.970 |
Why?
| Prosthesis Implantation | 2 | 2016 | 43 | 0.940 |
Why?
| Risk Assessment | 6 | 2020 | 806 | 0.940 |
Why?
| Atrial Flutter | 3 | 2011 | 13 | 0.930 |
Why?
| Middle Aged | 30 | 2021 | 11209 | 0.930 |
Why?
| Heart Arrest | 3 | 2011 | 48 | 0.910 |
Why?
| Echocardiography, Three-Dimensional | 1 | 2021 | 3 | 0.890 |
Why?
| Prosthesis Failure | 2 | 2018 | 534 | 0.880 |
Why?
| Female | 35 | 2021 | 18253 | 0.870 |
Why?
| Chest Pain | 1 | 2021 | 23 | 0.870 |
Why?
| Radiation Dosage | 2 | 2020 | 35 | 0.850 |
Why?
| Ventricular Dysfunction, Left | 3 | 2020 | 54 | 0.840 |
Why?
| Septal Occluder Device | 1 | 2020 | 17 | 0.830 |
Why?
| Atrial Appendage | 2 | 2020 | 47 | 0.820 |
Why?
| Treatment Outcome | 21 | 2021 | 3910 | 0.800 |
Why?
| Male | 32 | 2021 | 17583 | 0.760 |
Why?
| Electric Countershock | 2 | 2017 | 21 | 0.750 |
Why?
| Dextrocardia | 1 | 2018 | 4 | 0.730 |
Why?
| Thyroid Diseases | 1 | 2018 | 21 | 0.720 |
Why?
| Ventricular Fibrillation | 2 | 2016 | 27 | 0.700 |
Why?
| Thyroid Gland | 1 | 2018 | 62 | 0.690 |
Why?
| Imaging, Three-Dimensional | 1 | 2019 | 233 | 0.690 |
Why?
| Accessory Atrioventricular Bundle | 1 | 2017 | 3 | 0.690 |
Why?
| Tachycardia, Supraventricular | 1 | 2017 | 4 | 0.690 |
Why?
| Atrioventricular Block | 1 | 2017 | 4 | 0.690 |
Why?
| Heart Block | 1 | 2017 | 12 | 0.680 |
Why?
| Blood Vessel Prosthesis Implantation | 1 | 2018 | 44 | 0.670 |
Why?
| Cardiac Catheterization | 1 | 2018 | 110 | 0.660 |
Why?
| Fluoroscopy | 4 | 2020 | 54 | 0.640 |
Why?
| Time Factors | 9 | 2021 | 1902 | 0.630 |
Why?
| Risk Factors | 9 | 2020 | 2664 | 0.620 |
Why?
| Therapeutic Occlusion | 1 | 2015 | 3 | 0.600 |
Why?
| Vena Cava, Inferior | 1 | 2015 | 14 | 0.600 |
Why?
| Intraoperative Care | 1 | 2016 | 58 | 0.600 |
Why?
| Torsades de Pointes | 2 | 2007 | 11 | 0.570 |
Why?
| Takotsubo Cardiomyopathy | 2 | 2015 | 20 | 0.560 |
Why?
| Thrombosis | 2 | 2014 | 67 | 0.550 |
Why?
| Long QT Syndrome | 2 | 2020 | 14 | 0.540 |
Why?
| Aged | 19 | 2021 | 10295 | 0.520 |
Why?
| Echocardiography, Transesophageal | 3 | 2014 | 52 | 0.490 |
Why?
| Adenosine | 2 | 2009 | 15 | 0.490 |
Why?
| Electrophysiologic Techniques, Cardiac | 4 | 2019 | 9 | 0.480 |
Why?
| Shock, Cardiogenic | 1 | 2012 | 10 | 0.480 |
Why?
| Stroke | 4 | 2012 | 367 | 0.480 |
Why?
| Warfarin | 5 | 2018 | 60 | 0.480 |
Why?
| Hypothermia, Induced | 1 | 2012 | 25 | 0.470 |
Why?
| Models, Animal | 1 | 2012 | 149 | 0.470 |
Why?
| Coronary Vasospasm | 1 | 2012 | 2 | 0.470 |
Why?
| Feasibility Studies | 4 | 2021 | 281 | 0.470 |
Why?
| Myocardial Ischemia | 1 | 2012 | 63 | 0.450 |
Why?
| Heart Valves | 1 | 2011 | 6 | 0.450 |
Why?
| Equipment Design | 6 | 2022 | 198 | 0.450 |
Why?
| Tachycardia | 2 | 2009 | 43 | 0.440 |
Why?
| Thiophenes | 1 | 2011 | 14 | 0.440 |
Why?
| Electric Injuries | 2 | 2011 | 4 | 0.430 |
Why?
| Heart Atria | 1 | 2011 | 89 | 0.430 |
Why?
| Granuloma, Foreign-Body | 1 | 2010 | 4 | 0.420 |
Why?
| Recurrence | 3 | 2020 | 389 | 0.420 |
Why?
| Serotonin Uptake Inhibitors | 1 | 2011 | 90 | 0.420 |
Why?
| Hospitals | 1 | 2011 | 142 | 0.410 |
Why?
| Defibrillators | 1 | 2010 | 2 | 0.400 |
Why?
| Coronary Occlusion | 1 | 2010 | 2 | 0.400 |
Why?
| Cardiography, Impedance | 1 | 2010 | 3 | 0.400 |
Why?
| Transposition of Great Vessels | 2 | 2008 | 7 | 0.390 |
Why?
| Prospective Studies | 6 | 2020 | 1934 | 0.380 |
Why?
| Cardiomyopathies | 1 | 2009 | 39 | 0.380 |
Why?
| Ventricular Function, Left | 3 | 2020 | 63 | 0.370 |
Why?
| Iliac Vein | 1 | 2008 | 5 | 0.360 |
Why?
| Equipment Failure | 1 | 2008 | 50 | 0.360 |
Why?
| Prognosis | 4 | 2018 | 1028 | 0.360 |
Why?
| Pericardium | 1 | 2008 | 27 | 0.350 |
Why?
| Career Choice | 1 | 2008 | 33 | 0.350 |
Why?
| Pediatrics | 1 | 2008 | 48 | 0.350 |
Why?
| Retrospective Studies | 7 | 2021 | 3591 | 0.350 |
Why?
| Heart | 3 | 2022 | 110 | 0.340 |
Why?
| Heart Defects, Congenital | 1 | 2008 | 65 | 0.340 |
Why?
| Myocardial Infarction | 5 | 2020 | 187 | 0.330 |
Why?
| Cardiology | 1 | 2008 | 102 | 0.320 |
Why?
| Critical Illness | 1 | 2008 | 125 | 0.320 |
Why?
| Physicians | 1 | 2008 | 120 | 0.310 |
Why?
| Tachycardia, Paroxysmal | 1 | 2006 | 3 | 0.310 |
Why?
| Azithromycin | 1 | 2005 | 3 | 0.300 |
Why?
| Animals | 6 | 2022 | 5312 | 0.300 |
Why?
| Registries | 3 | 2021 | 214 | 0.290 |
Why?
| Cardiopulmonary Bypass | 2 | 2015 | 52 | 0.270 |
Why?
| Coronary Angiography | 3 | 2011 | 106 | 0.270 |
Why?
| Cardiac Surgical Procedures | 1 | 2005 | 98 | 0.270 |
Why?
| Bradycardia | 2 | 2021 | 29 | 0.270 |
Why?
| Reoperation | 2 | 2020 | 938 | 0.260 |
Why?
| Predictive Value of Tests | 4 | 2019 | 637 | 0.260 |
Why?
| Aged, 80 and over | 9 | 2020 | 5234 | 0.260 |
Why?
| Exercise Test | 2 | 2020 | 123 | 0.240 |
Why?
| Diagnosis, Differential | 3 | 2020 | 467 | 0.240 |
Why?
| Vectorcardiography | 1 | 2020 | 1 | 0.210 |
Why?
| Metabolic Equivalent | 1 | 2020 | 3 | 0.210 |
Why?
| Sinoatrial Node | 1 | 2020 | 4 | 0.210 |
Why?
| Cardiovascular Diseases | 1 | 2005 | 410 | 0.210 |
Why?
| Ventricular Function, Right | 2 | 2019 | 7 | 0.210 |
Why?
| Prone Position | 1 | 2020 | 25 | 0.210 |
Why?
| Exercise Tolerance | 1 | 2020 | 29 | 0.210 |
Why?
| Electrophysiological Phenomena | 1 | 2020 | 16 | 0.210 |
Why?
| Echocardiography | 2 | 2019 | 197 | 0.210 |
Why?
| Lasers | 1 | 2020 | 15 | 0.210 |
Why?
| Adult | 9 | 2021 | 9779 | 0.200 |
Why?
| Myocardial Perfusion Imaging | 2 | 2013 | 63 | 0.200 |
Why?
| Endoscopy, Gastrointestinal | 2 | 2012 | 12 | 0.200 |
Why?
| Treatment Failure | 1 | 2020 | 187 | 0.190 |
Why?
| Thromboembolism | 2 | 2011 | 37 | 0.190 |
Why?
| Antiviral Agents | 1 | 2020 | 139 | 0.190 |
Why?
| Stroke Volume | 4 | 2021 | 64 | 0.190 |
Why?
| Thyroid Function Tests | 1 | 2018 | 14 | 0.180 |
Why?
| Pilot Projects | 1 | 2020 | 455 | 0.180 |
Why?
| Diagnostic Errors | 1 | 2018 | 48 | 0.180 |
Why?
| Ablation Techniques | 1 | 2017 | 4 | 0.170 |
Why?
| Swine | 3 | 2022 | 117 | 0.170 |
Why?
| History, 21st Century | 1 | 2017 | 39 | 0.160 |
Why?
| Sensitivity and Specificity | 3 | 2015 | 580 | 0.160 |
Why?
| Diffusion of Innovation | 1 | 2017 | 41 | 0.160 |
Why?
| History, 20th Century | 1 | 2017 | 94 | 0.160 |
Why?
| Forecasting | 1 | 2017 | 134 | 0.150 |
Why?
| Constriction | 1 | 2015 | 6 | 0.150 |
Why?
| Exercise | 1 | 2020 | 454 | 0.150 |
Why?
| Algorithms | 2 | 2019 | 412 | 0.150 |
Why?
| Electrodes | 1 | 2015 | 16 | 0.140 |
Why?
| Patient Selection | 2 | 2014 | 264 | 0.140 |
Why?
| Neoplasms, Radiation-Induced | 1 | 2014 | 18 | 0.140 |
Why?
| Heart Neoplasms | 1 | 2014 | 21 | 0.140 |
Why?
| Heart Conduction System | 2 | 2022 | 29 | 0.130 |
Why?
| Severity of Illness Index | 2 | 2019 | 1240 | 0.120 |
Why?
| Hemodynamics | 1 | 2013 | 103 | 0.120 |
Why?
| Heart-Assist Devices | 1 | 2013 | 31 | 0.120 |
Why?
| Sex Factors | 2 | 2012 | 542 | 0.120 |
Why?
| Adolescent | 3 | 2009 | 2667 | 0.120 |
Why?
| Hemostasis, Endoscopic | 1 | 2012 | 1 | 0.120 |
Why?
| Sarcoma | 1 | 2014 | 139 | 0.110 |
Why?
| Tomography, Emission-Computed, Single-Photon | 1 | 2013 | 84 | 0.110 |
Why?
| Gastrointestinal Hemorrhage | 1 | 2012 | 29 | 0.110 |
Why?
| Intercostal Muscles | 1 | 2011 | 5 | 0.110 |
Why?
| Spasm | 1 | 2011 | 7 | 0.110 |
Why?
| Coronary Sinus | 1 | 2011 | 5 | 0.110 |
Why?
| Therapeutic Irrigation | 2 | 2022 | 69 | 0.110 |
Why?
| Patient Acceptance of Health Care | 1 | 2012 | 85 | 0.110 |
Why?
| Primary Health Care | 1 | 2013 | 106 | 0.110 |
Why?
| Hormone Replacement Therapy | 1 | 2011 | 46 | 0.110 |
Why?
| Hemorrhage | 1 | 2011 | 90 | 0.100 |
Why?
| Catechin | 1 | 2010 | 3 | 0.100 |
Why?
| Plant Preparations | 1 | 2010 | 9 | 0.100 |
Why?
| Anti-Obesity Agents | 1 | 2010 | 7 | 0.100 |
Why?
| Young Adult | 1 | 2017 | 2277 | 0.100 |
Why?
| Dietary Supplements | 1 | 2010 | 62 | 0.100 |
Why?
| Epicardial Mapping | 1 | 2009 | 4 | 0.100 |
Why?
| Breast Neoplasms | 1 | 2014 | 442 | 0.100 |
Why?
| Fatal Outcome | 1 | 2010 | 75 | 0.100 |
Why?
| Sodium-Potassium-Exchanging ATPase | 1 | 2009 | 8 | 0.100 |
Why?
| Point-of-Care Systems | 1 | 2010 | 29 | 0.100 |
Why?
| Infusions, Intravenous | 1 | 2009 | 89 | 0.100 |
Why?
| Magnesium | 1 | 2009 | 52 | 0.100 |
Why?
| Cardiac Electrophysiology | 1 | 2008 | 3 | 0.090 |
Why?
| Radiotherapy | 2 | 2014 | 65 | 0.090 |
Why?
| Signal Processing, Computer-Assisted | 2 | 2019 | 44 | 0.090 |
Why?
| Postoperative Period | 1 | 2010 | 295 | 0.090 |
Why?
| Autopsy | 1 | 2010 | 340 | 0.090 |
Why?
| Antihypertensive Agents | 1 | 2009 | 91 | 0.090 |
Why?
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2009 | 81 | 0.090 |
Why?
| Physician-Patient Relations | 1 | 2008 | 47 | 0.090 |
Why?
| Drug Interactions | 1 | 2007 | 70 | 0.080 |
Why?
| Electronics, Medical | 1 | 2007 | 2 | 0.080 |
Why?
| Infusion Pumps, Implantable | 1 | 2007 | 13 | 0.080 |
Why?
| Electromagnetic Fields | 1 | 2007 | 12 | 0.080 |
Why?
| Electrocoagulation | 1 | 2007 | 14 | 0.080 |
Why?
| Women's Health | 1 | 2009 | 228 | 0.080 |
Why?
| Chicago | 2 | 2020 | 955 | 0.080 |
Why?
| Respiratory Tract Infections | 1 | 2005 | 25 | 0.070 |
Why?
| Length of Stay | 2 | 2005 | 377 | 0.070 |
Why?
| United States | 2 | 2019 | 2539 | 0.070 |
Why?
| Patient Compliance | 1 | 2007 | 200 | 0.070 |
Why?
| Practice Guidelines as Topic | 1 | 2007 | 389 | 0.070 |
Why?
| Age Factors | 2 | 2020 | 943 | 0.070 |
Why?
| Heparin, Low-Molecular-Weight | 1 | 2003 | 24 | 0.060 |
Why?
| Randomized Controlled Trials as Topic | 2 | 2021 | 375 | 0.060 |
Why?
| Electrosurgery | 1 | 2002 | 5 | 0.060 |
Why?
| Electromagnetic Phenomena | 1 | 2002 | 3 | 0.060 |
Why?
| Lithotripsy | 1 | 2002 | 4 | 0.060 |
Why?
| Security Measures | 1 | 2002 | 4 | 0.060 |
Why?
| Electric Power Supplies | 1 | 2002 | 3 | 0.060 |
Why?
| Electricity | 1 | 2002 | 8 | 0.060 |
Why?
| Industry | 1 | 2002 | 11 | 0.060 |
Why?
| Electric Conductivity | 1 | 2002 | 85 | 0.060 |
Why?
| Environmental Exposure | 1 | 2002 | 17 | 0.060 |
Why?
| Electric Stimulation Therapy | 1 | 2002 | 43 | 0.060 |
Why?
| Endocardium | 1 | 2022 | 4 | 0.060 |
Why?
| Anti-Bacterial Agents | 1 | 2005 | 412 | 0.060 |
Why?
| Thermography | 1 | 2021 | 13 | 0.060 |
Why?
| Reproducibility of Results | 2 | 2015 | 886 | 0.060 |
Why?
| Temperature | 1 | 2021 | 85 | 0.050 |
Why?
| Hyperthyroidism | 1 | 2020 | 15 | 0.050 |
Why?
| Heart Valve Diseases | 1 | 2020 | 32 | 0.050 |
Why?
| Patient Positioning | 1 | 2020 | 35 | 0.050 |
Why?
| Disease-Free Survival | 1 | 2020 | 241 | 0.050 |
Why?
| Pulmonary Disease, Chronic Obstructive | 1 | 2020 | 42 | 0.050 |
Why?
| Monitoring, Physiologic | 1 | 2020 | 100 | 0.050 |
Why?
| Alcoholism | 1 | 2020 | 90 | 0.050 |
Why?
| Sleep Apnea, Obstructive | 1 | 2020 | 72 | 0.050 |
Why?
| Pennsylvania | 1 | 2019 | 15 | 0.050 |
Why?
| Recovery of Function | 1 | 2020 | 309 | 0.050 |
Why?
| Renal Insufficiency, Chronic | 1 | 2020 | 103 | 0.050 |
Why?
| Coronary Artery Disease | 1 | 2020 | 159 | 0.050 |
Why?
| Hypertension | 1 | 2020 | 283 | 0.040 |
Why?
| Cohort Studies | 2 | 2014 | 2014 | 0.040 |
Why?
| Incidence | 1 | 2020 | 829 | 0.040 |
Why?
| Follow-Up Studies | 2 | 2013 | 2028 | 0.040 |
Why?
| Disease Progression | 1 | 2020 | 861 | 0.040 |
Why?
| Obesity | 1 | 2020 | 338 | 0.040 |
Why?
| Magnetic Resonance Imaging | 1 | 2002 | 1273 | 0.040 |
Why?
| Hospitalization | 1 | 2019 | 359 | 0.040 |
Why?
| Miniaturization | 1 | 2015 | 3 | 0.040 |
Why?
| Equipment Failure Analysis | 1 | 2015 | 116 | 0.030 |
Why?
| Perfusion | 1 | 2013 | 23 | 0.030 |
Why?
| Drug Monitoring | 1 | 2012 | 29 | 0.030 |
Why?
| Cause of Death | 1 | 2013 | 78 | 0.030 |
Why?
| Guideline Adherence | 1 | 2013 | 77 | 0.030 |
Why?
| Administration, Oral | 1 | 2012 | 164 | 0.030 |
Why?
| Data Collection | 1 | 2012 | 120 | 0.030 |
Why?
| Decision Support Techniques | 1 | 2012 | 55 | 0.030 |
Why?
| Ventricular Dysfunction, Right | 1 | 2011 | 16 | 0.030 |
Why?
| Sympathomimetics | 1 | 2010 | 7 | 0.030 |
Why?
| Tomography, X-Ray Computed | 1 | 2014 | 891 | 0.020 |
Why?
| Teaching Materials | 1 | 2007 | 10 | 0.020 |
Why?
| Equipment Safety | 1 | 2007 | 13 | 0.020 |
Why?
| Technology Assessment, Biomedical | 1 | 2007 | 5 | 0.020 |
Why?
| Patient Education as Topic | 1 | 2007 | 192 | 0.020 |
Why?
| Logistic Models | 1 | 2007 | 479 | 0.020 |
Why?
| Ambulatory Care | 1 | 2003 | 90 | 0.020 |
Why?
| Disease Management | 1 | 2003 | 147 | 0.010 |
Why?
| Emergency Service, Hospital | 1 | 2003 | 180 | 0.010 |
Why?
|
|
Trohman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|